Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
9.13
+0.15 (1.67%)
At close: Nov 22, 2024, 4:00 PM
9.01
-0.12 (-1.31%)
After-hours: Nov 22, 2024, 6:57 PM EST
Cogent Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -242.3 | -192.41 | -140.24 | -72.27 | -74.81 | -31.83 | |
| Depreciation & Amortization | 4.04 | 3.59 | 5.88 | 1.99 | 0.72 | 1.29 | |
| Loss (Gain) From Sale of Assets | 0.01 | 0.01 | - | - | -7.49 | -0.08 | |
| Asset Writedown & Restructuring Costs | - | - | -0.4 | - | 44.81 | - | |
| Loss (Gain) From Sale of Investments | -9.32 | -5.17 | -1.64 | - | - | -0.05 | |
| Stock-Based Compensation | 38.61 | 30.62 | 18.37 | 11.69 | 6.02 | 3.24 | |
| Other Operating Activities | - | -1.7 | -1.36 | -0.34 | 0.22 | - | |
| Change in Accounts Receivable | - | - | - | - | 2 | -0.33 | |
| Change in Accounts Payable | 5.19 | 4.81 | 2.36 | 2.75 | -2.45 | 1.66 | |
| Change in Unearned Revenue | - | - | - | - | -1.32 | -16.63 | |
| Change in Other Net Operating Assets | 12.48 | 6.63 | -1.61 | -2.58 | -3.55 | 1.22 | |
| Operating Cash Flow | -191.28 | -153.62 | -118.64 | -58.76 | -35.85 | -41.51 | |
| Capital Expenditures | -0.81 | -2.8 | -6.86 | -1.72 | - | -0.03 | |
| Sale of Property, Plant & Equipment | - | - | - | - | 0.32 | 0.2 | |
| Investment in Securities | -12.09 | -95.03 | -117.86 | - | - | 22.99 | |
| Other Investing Activities | - | - | - | - | 8.1 | - | |
| Investing Cash Flow | -12.91 | -97.82 | -124.72 | -1.72 | 8.42 | 23.16 | |
| Issuance of Common Stock | 226.03 | 174.24 | 174.36 | 39.26 | 140.56 | 0.11 | |
| Other Financing Activities | -11.6 | -10.7 | -10.8 | -1.29 | -12.76 | - | |
| Financing Cash Flow | 214.43 | 163.54 | 163.56 | 37.98 | 232.2 | 0.11 | |
| Net Cash Flow | 10.24 | -87.91 | -79.8 | -22.51 | 204.77 | -18.25 | |
| Free Cash Flow | -192.1 | -156.42 | -125.5 | -60.48 | -35.85 | -41.55 | |
| Free Cash Flow Margin | - | - | - | - | -455.47% | -184.66% | |
| Free Cash Flow Per Share | -1.96 | -1.96 | -2.14 | -1.56 | -3.24 | -5.45 | |
| Levered Free Cash Flow | -101.88 | -86.68 | -67.08 | -31.78 | -15.46 | - | |
| Unlevered Free Cash Flow | -101.88 | -86.68 | -67.08 | -31.78 | -15.46 | - | |
| Change in Net Working Capital | -19.06 | -11.99 | -7.93 | -3.48 | 0.14 | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.